ReviewOxidative medicine and cellular longevity2018

Therapeutic Use of mTOR Inhibitors in Renal Diseases: Advances, Drawbacks, and Challenges.

Sofia D Viana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.